ReviewLeukemia2019

Transforming growth factor (TGF)-β pathway as a therapeutic target in lower risk myelodysplastic syndromes.

Jan Philipp Bewersdorf et al.PubMed ↗Publisher ↗

No numbers read from the abstract.